Skip to main content
Premium Trial:

Request an Annual Quote

Life, Liberty, and...Personal Genomics?

Seems many are speaking up about the attempt of New York and California to restrict personal genetic testing. Over at The Personal Genome, Jason Bobe calls the cease-and-desist letters a form of "biocensorship," while an editorial in Nature Biotechnology wonders how personalized medicine is to advance if the current state of medicine isn't changed. Companies like 23andMe and Navigenics are allowing people to take personal responsibility for their health, a move that obviously doesn't sit well with today's "medical gatekeepers," the article says. And Tim O'Reilly makes a good point: 23andMe isn't just providing a service to consumers; the company is gathering the data needed for future studies. "23andme (and presumably other similar services) have come up with a very clever hack that will vastly increase the available store of genetic information that can be used to cross check various medical studies," he writes.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.